Type 2 Diabetes

>

Latest News

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
FDA Clears Eversense 365, Marking First 1-Year CGM Option in Diabetes

September 18th 2024

The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.

GLP-1 RA Linked to Lower Risk of Cirrhosis Development in Patients with MASLD
GLP-1 RA Linked to Lower Risk of Cirrhosis Development in Patients with MASLD

September 16th 2024

HCPLive Endocrinology Month In Review August 2024
Endocrinology Month in Review: August 2024

September 10th 2024

Brendon Neuen, MBBS, PhD | Credit: X.com
Brendon Neuen, MBBS, PhD: Expanding Evidence of Combination Therapy with GLP-1 RAs and SGLT2 Inhibitors

September 1st 2024

Brian Callaghan, MD, MS | Credit: Michigan Medicine
Study Finds Diabetes Complications and Mental Health Disorders Are a 2-Way Street

August 27th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.